PT-141 (Bremelanotide)
AdjacentResearch ongoing — see primary literature for current evidence.
Kisspeptin
AdjacentGnRH pulse restoration; reproductive axis longevity
Clinical Decision Framework
When evaluating PT-141 (Bremelanotide) versus Kisspeptin for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize PT-141 (Bremelanotide):
Select PT-141 (Bremelanotide) when the primary clinical objective aligns with its core mechanism: melanocortin receptor agonist (mc3r/mc4r) that acts centrally in the hypothalamus to stimulate sexual arousal independent of vascular mechanisms.. This is particularly relevant for protocols focused on libido enhancement and sexual arousal in both men and women..
When to prioritize Kisspeptin:
Conversely, Kisspeptin is the superior choice when targeting hypothalamic neuropeptide that activates gnrh neurons to stimulate lh/fsh release, regulating reproductive function and libido., making it the preferred agent for reproductive hormone regulation, fertility support, and libido enhancement..
Begin Your Age Reversal Protocol for PT-141 (Bremelanotide) or Kisspeptin
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing